In a significant move towards advancing agricultural biotechnology, Biotalys and 21st.BIO have forged a strategic partnership aimed at enhancing the production of innovative protein-based biocontrol products. This collaboration marks a pivotal step in the evolution of sustainable agricultural practices, harnessing cutting-edge fermentation technology to create solutions that promise to reshape the market landscape.
Partnership Overview
Biotalys, headquartered in Ghent, Belgium, specializes in developing agricultural biocontrol solutions, while 21st.BIO, based in Søborg, Denmark, is recognized for its advanced precision fermentation technology. By combining their expertise, these companies aim to expedite the production process for Biotalys’ AGROBODY line of biocontrol products, making them more accessible and cost-effective for farmers.
Leveraging Precision Fermentation
21st.BIO’s fermentation platform stands out in the industry, boasting a legacy of refinement that spans over four decades. This platform utilizes production strains that have been proven in various commercial applications. The collaboration will integrate 21st.BIO’s advanced capabilities with the prior innovations of Biotalys and Novonesis, creating a seamless approach to process development and large-scale manufacturing.
Strengthening the AGROBODY Platform
Kevin Helash, CEO of Biotalys, emphasizes the importance of this partnership in solidifying the technical framework of the AGROBODY platform. By uniting 21st.BIO’s fermentation expertise with Biotalys’ innovative spirit, they are laying a robust foundation to support a diverse and expanding product portfolio. The synergy between the two companies enhances their ability to deliver next-generation agricultural solutions to market.
Advancing Commercialization Efforts
The partnership is timely, as Biotalys is in the process of transitioning from its previous collaboration with Novonesis. Discussions are underway with potential manufacturing and distribution partners worldwide to solidify its commercialization strategy. With a keen focus on the upcoming launch of EVOCA NG, Biotalys plans to have all essential arrangements finalized ahead of its anticipated registration in the U.S. and Europe, projected for 2028-29 and 2029-30, respectively.
Introducing EVOCA NG
EVOCA NG represents a groundbreaking biofungicide developed to combat key fungal diseases such as Botrytis and powdery mildew, particularly beneficial for fruit and vegetable growers. As Biotalys’ inaugural commercial product, EVOCA NG is poised to capture a significant share of a market valued at approximately USD 1.2 billion across the U.S., Europe, and Brazil. This launch is a testament to the efficacy of protein-based biocontrols in promoting sustainable agricultural practices.
Commitment to Sustainability
The collaboration stands as a commitment to fostering a safer and more secure food system. Thomas Schmidt, co-founder and CEO of 21st.BIO, emphasizes the ambition to translate lab-scale innovations into dependable, industrial-scale biotech production. By reducing production costs and accelerating time-to-market, the partnership aims to make powerful biocontrol solutions like EVOCA NG viable options for growers worldwide.
Future Outlook
As Biotalys prepares to launch its first commercial product, the implications of this partnership extend beyond immediate market benefits. The integration of precision fermentation technology not only enhances product reliability and cost-effectiveness but also aligns with the broader goal of sustainable agriculture. The collaboration embodies a forward-thinking approach to biocontrols, ensuring that agricultural practices evolve in tandem with environmental considerations.
- Key Takeaways:
- Biotalys and 21st.BIO collaborate to boost production of biocontrol products.
- The partnership utilizes advanced precision fermentation technology.
- EVOCA NG is set to be Biotalys’ first commercial biofungicide, targeting major markets.
- The collaboration emphasizes sustainability and cost-effectiveness in agricultural practices.
- Strategic discussions are ongoing to ensure successful commercialization ahead of product launches.
In conclusion, the partnership between Biotalys and 21st.BIO heralds a new era for agricultural biotechnology. By merging their strengths, they are not only accelerating the development of innovative biocontrol solutions but also reinforcing their commitment to sustainability within the agricultural sector. The future looks promising as they work towards a safer and more reliable food supply for all.
Read more → www.chemengonline.com